Qube Research & Technologies LTD Molecular Partners Ag Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$8.35 Million0.44% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$5.09 Million0.24% of portfolio
-
Ubs Group Ag6.87KShares$25,8380.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,3790.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,0110.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $122M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...